SLC2A8
Basic information
Region (hg38): 9:127397138-127408424
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (64 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC2A8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014580.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 62 | 65 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 62 | 4 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC2A8 | protein_coding | protein_coding | ENST00000373371 | 10 | 11283 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.02e-7 | 0.749 | 125355 | 0 | 374 | 125729 | 0.00149 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.349 | 246 | 262 | 0.939 | 0.0000154 | 2982 |
| Missense in Polyphen | 85 | 80.393 | 1.0573 | 949 | ||
| Synonymous | 0.976 | 107 | 121 | 0.887 | 0.00000809 | 1031 |
| Loss of Function | 1.26 | 12 | 17.7 | 0.678 | 7.58e-7 | 206 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00244 | 0.00243 |
| Ashkenazi Jewish | 0.00450 | 0.00448 |
| East Asian | 0.00296 | 0.00267 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00137 | 0.00135 |
| Middle Eastern | 0.00296 | 0.00267 |
| South Asian | 0.00128 | 0.00127 |
| Other | 0.00196 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: Insulin-regulated facilitative glucose transporter. Binds cytochalasin B in a glucose-inhibitable manner. Seems to be a dual-specific sugar transporter as it is inhibitable by fructose (By similarity). {ECO:0000250}.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Vesicle-mediated transport;Membrane Trafficking;SLC-mediated transmembrane transport;Transport of small molecules;Fructose and mannose metabolism;Galactose metabolism;Clathrin-mediated endocytosis;Cellular hexose transport;Cargo recognition for clathrin-mediated endocytosis
(Consensus)
Recessive Scores
- pRec
- 0.195
Haploinsufficiency Scores
- pHI
- 0.136
- hipred
- Y
- hipred_score
- 0.570
- ghis
- 0.497
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.342
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc2a8
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype;
Gene ontology
- Biological process
- response to hypoxia;carbohydrate metabolic process;male meiosis I;insulin receptor signaling pathway;hexose transmembrane transport;membrane organization;proton transmembrane transport;glucose transmembrane transport
- Cellular component
- lysosomal membrane;plasma membrane;integral component of plasma membrane;synaptic vesicle;clathrin-coated vesicle membrane
- Molecular function
- carbohydrate:proton symporter activity;glucose transmembrane transporter activity;glucose binding;D-glucose transmembrane transporter activity